Navigation Links
Cataract surgery saves $123.4 billion in direct, indirect costs, delivers a 4,567 percent return to society

NEW ORLEANS Nov. 15, 2013 Cataract surgeries performed over one year eventually save $123.4 billion over 13 years and delivers a 4,567 percent financial return on investment to society according to the results of a cost-utility study, published online today in the Academy's official journal, Ophthalmology, and will be presented on Nov. 17 at the world's largest ophthalmic conference, the American Academy of Ophthalmology's 117th Annual Meeting, in New Orleans. Researchers say that the results prove that healthcare interventions create substantial economic wealth.

Cataract, which affects approximately 24.5 million Americans, is a condition in which the eye's lens becomes cloudy and can lead to blindness if not treated through surgery. Cataract surgery is the most common, major ophthalmic surgical procedure. Researchers from the Center for Value-Based Medicine used data from the National Study of Cataract Outcomes. They measured both the direct and indirect costs associated with vision loss due to cataract and compared these costs to the value of cataract surgery in 2012. They also compared their findings to similar studies that were also conducted using the National Study of Cataract Outcomes in both 2000 and 1985.

The majority of the $123.4 billion savings are in patient cost savings and Medicare savings, which accounted for 39.4 percent 29.5 percent, respectively. Other gains included employment/productivity (20.6 percent), Medicaid (2.7 percent) and other insurers (7.8 percent). This means that for each cataract surgery on a single eye, which costs an average of $2,653, the savings will amount to $121,198. Additionally, the researchers found that over the 13-year model, cataract surgery yielded a 4,567 percent financial return on investment to society.

When compared to the estimated costs in previous study years, it was found that the overall cataract surgery cost in 2012 was 34.4 percent less expensive than in 2000 and 85 percent less expensive than in 1985 after adjusting for inflation. Furthermore, the inflation-adjusted physician fee in 2012 was only 10.1 percent of what it had been in 1985.

In terms of the patient value, the researchers found that cataract surgery yields an overall 36.2 percent gain in quality-of-life when performed in both eyes. Without cataract surgery, cataract-related vision loss can become so bad that individuals lose their independence in a variety of ways, such as being able to drive, read their mail, keep up their home and administer their medications.

"Most people regard healthcare costs, which are estimated by the Centers for Medicare and Medicaid at $2.81 trillion in 2012, as expenditures and not investment dollars that return patient value and financial value," said lead researcher Melissa M. Brown, M.D., of the Center for Value-Based Medicine and Wills Eye Hospital. "Our data demonstrates that this approach is far too simplistic and that estimating the return on investment provides a more complete picture. Cataract surgery is a paradigm for the premise that healthcare interventions, in addition to creating substantial patient value, can also create considerable economic wealth."


Contact: Media Relations
American Academy of Ophthalmology

Related medicine news :

1. Femtosecond Lasers for Cataract Surgery Market
2. EyeCare 20/20, Short Hills Ophthalmology and the Laser Vision Center of New Jersey to Provide Cataract Surgery To 50 Patients this November
3. Detecting Cataracts Early May Lead to a Longer Life
4. Statins prevent cataracts
5. Cataract Prevention for Senior Citizens
6. Global Cataract Surgery Devices Market 2019 – IOL, OVD & Phacoemulsification Equipment Analysis in New Research Reports at
7. Femtosecond Cataract Laser -- TRUE Laser Cataract Surgery Has Arrived
8. Looking at outcomes important to patients may improve results of cataract surgery
9. Femtosecond Laser Cataract Surgery Equipment Market – 2019 Forecast in New Research Report at
10. Turner Eye Institute Now Using New LenSx Laser for Cataracts
11. Houston Surgeon Can Now Treat Open Angle Glaucoma During Cataract Surgery
Post Your Comments:
(Date:12/1/2015)... , ... December 01, 2015 , ... According to an ... groups has filed a discrimination claim against the U.S. Department of Health and Human ... Affordable Care Act (ACA) plans are breaking the clause in the law prohibiting the ...
(Date:12/1/2015)... ... December 01, 2015 , ... Califia Farms , one ... its iconic bottle has won top honors in Beverage World Magazine’s Global Packaging Design ... announced that it has been selected as a 2015 U.S.A. Taste Champion in the ...
(Date:12/1/2015)... ... , ... Growth in medical payments per workers’ compensation claim in Louisiana slowed ... nonhospital care, according to a recent study by the Workers Compensation Research Institute (WCRI). ... medical payments per claim with more than seven days of lost time continued to ...
(Date:12/1/2015)... ... December 01, 2015 , ... CloudLIMS today announced ... Bridge Business Awards under the New Products and Services category for its innovative ... sample management software that helps labs organize data and track samples with ...
(Date:12/1/2015)... ... December 01, 2015 , ... Diabetic foot wounds ... Podiatrists are well aware that psychology-based patient non-compliance (disobedience of a health care ... to diseases of the diabetic foot. The American Board of Multiple Specialties ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... 1, 2015 --> ... report "Nucleic Acid Labeling Market by Product (Reagents & ... Primer, In Vitro Transcription, Reverse Transcription, End Labeling), by ... The global market is expected to reach USD 1,925.7 ... growing at a CAGR of 8.65%. Browse ...
(Date:12/1/2015)... Russia has always been a country of choice for ... Europe in 2015 were tested in phase II-III ... has always been a country of choice for global multi-center phase ... in 2015 were tested in phase II-III clinical trials ... always been a country of choice for global multi-center phase III clinical ...
(Date:12/1/2015)... Dec. 1, 2015 Relmada Therapeutics, Inc. (OTCQB: RLMD), ... chronic pain, announced today that the company will present at ... December 1-3 at the Luxe Sunset Boulevard Hotel in ... CEO of Relmada Therapeutics, will present on Thursday, December 3, ... . Please register at least 10 minutes prior ...
Breaking Medicine Technology: